[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100556675":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":31,"centralContacts":35,"locations":40,"responsibleParty":55,"collaborators":58,"id":63,"slug":26,"hasResults":64,"nctId":65,"briefTitle":66,"officialTitle":66,"acronym":26,"eligibilityCriteria":67,"healthyVolunteers":68,"sex":69,"minAge":70,"maxAge":71,"enrollmentInfo":72,"targetDuration":26,"studyType":75,"phases":76,"briefSummary":78,"conditions":79,"keywords":26,"overallStatus":42,"whyStopped":26,"lastUpdateSubmitDate":81,"lastUpdatePostDateStruct":82,"startDateStruct":85,"completionDateStruct":87,"leadSponsor":89,"locationsCount":90},{"fullName":5,"class":6},"National Healthcare Group Polyclinics","OTHER_GOV",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Usual care arm","ACTIVE_COMPARATOR","Participants will only be offered clinician-sampling for HPV DNA testing to determine if they are agreeable to undergo screening.",[13],"Diagnostic Test: Clinician-sampled HPV DNA test",{"label":15,"type":16,"description":17,"interventionNames":18},"Intervention arm","EXPERIMENTAL","Participants will be offered clinician-sampling or self-sampling for HPV DNA testing to determine if they are agreeable to undergo screening using either modality.",[19,13],"Diagnostic Test: Self-sampled HPV DNA testing",[21,27],{"type":22,"name":23,"description":24,"armGroupLabels":25,"otherNames":26},"DIAGNOSTIC_TEST","Self-sampled HPV DNA testing","Participants will be offered HPV DNA testing done through self-sampling (using self-sampling HPV DNA kits to obtain a mid-vaginal swab)",[15],null,{"type":22,"name":28,"description":29,"armGroupLabels":30,"otherNames":26},"Clinician-sampled HPV DNA test","Participants will be offered HPV DNA testing through clinician sampling (clinician-sampling (speculum examination by a nurse to obtain a cervical swab)",[15,9],[32],{"name":33,"affiliation":5,"role":34},"Ng Xin Rong, MBBS","PRINCIPAL_INVESTIGATOR",[36],{"name":33,"role":37,"phone":38,"phoneExt":26,"email":39},"CONTACT","+65 63553000","xin_rong_ng@nhgp.com.sg",[41],{"facility":5,"status":42,"city":43,"state":43,"zip":44,"country":43,"countryCode":45,"cosmosGeoPoint":46,"geoPoint":51,"contacts":52},"RECRUITING","Singapore","138543","SG",{"type":47,"coordinates":48},"Point",[49,50],103.85007,1.28967,{"lat":50,"lon":49},[53],{"name":33,"role":37,"phone":54,"phoneExt":26,"email":39},"65-90929973",{"type":34,"investigatorFullName":56,"investigatorTitle":57,"investigatorAffiliation":5,"oldNameTitle":26,"oldOrganization":26},"Ng Xin Rong","Family Physician",[59,61],{"name":60,"class":6},"National Healthcare Group, Singapore",{"name":62,"class":6},"KK Women's and Children's Hospital","100556675",false,"NCT06528184","Evaluating the Impact of Different Methods of HPV DNA Testing for Cervical Cancer Screening in Primary Care Settings","Inclusion Criteria:\n\n* 30-69 years old female Singapore citizens\n* Due for cervical cancer screening\n* Engaged in sexual intercourse before\n* Able to give informed consent\n* Able to read and communicate in English, Chinese or Malay\n\nExclusion Criteria:\n\n* Virgo intacta\n* Pregnancy\n* History of cervical cancer, precancerous cervical lesions and total hysterectomy",true,"FEMALE","30 Years","69 Years",{"count":73,"type":74},650,"ESTIMATED","INTERVENTIONAL",[77],"NA","Primary objective of the study is to determine the extent that offering of self-sampling in addition to clinician-sampling Human Papillomavirus (HPV) DNA testing will increase detection of HPV DNA through an increase in uptake rates of cervical cancer screening as compared to offering clinician-sampling HPV DNA testing alone.\n\nThe hypothesis is that offering additional self-sampling will increase the detection of high-risk HPV DNA by at least 7.7%.",[80],"Uterine Cervical Neoplasms","2025-02-05",{"date":83,"type":84},"2025-02-10","ACTUAL",{"date":86,"type":84},"2024-08-05",{"date":88,"type":74},"2026-12",{"name":5,"class":6},1]